Recombinant ITGAL (Efalizumab Biosimilar) antibody

Catalog No. ABIN5668044

Product Details anti-ITGAL (Efalizumab Biosimilar) Antibody

Target: ITGAL (Efalizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This ITGAL (Efalizumab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), Blocking Reagent (BR)

Specificity: Binds to human LFA-1.

Characteristics:

OriginalSpeciesName: Human

OriginalFormat: IgG1

Purification: Purified antibody.

Purity: > 98 % as determined by SDS-PAGE

Endotoxin Level: Endotoxin is < 1.0 EU/mg as determined by the LAL method

Immunogen: Efalizumab binds to CD11a, a subunit of leukocyte function antigen-1 (LFA-1), which is expressed on all leukocytes.

Clone: Hu1124

Isotype: IgG1 kappa

Application Details

Application Notes: Efalizumab binds to the LFA-1 alpha I domain blocking the ICAM-1 binding site via steric hindrance.

Restrictions: For Research Use only

Handling

Buffer: PBS with 0.02 % Proclin 300.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

Target Details for ITGAL (Efalizumab Biosimilar)

Target: ITGAL (Efalizumab Biosimilar)

Abstract: ITGAL (Efalizumab Biosimilar) Products

Synonyms: CD11A antibody, LFA-1 antibody, LFA1A antibody, integrin subunit alpha L antibody, ITGAL antibody

Target Type: Biosimilar

Background: LFA-1, integrin alpha L

UniProt: P20701